Bristol-Myers General Counsel Sandra Leung to retire in 2025

BRISTOL MYERS SQUIBB CO

Sandra Leung notified company of her retirement from EVP, General Counsel role, effective in 2025.
She will remain for a transition period until successor is appointed.
Retirement benefits will be provided under existing compensation plans.
Successor not yet named; transition expected before year-end.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Sandra Leung

Executive Vice President, General Counsel

BMY · BRISTOL MYERS SQUIBB CO

Filed: February 18, 2025, 6:59 PM ET

On February 14 , 2025, Sandra Leung notified Bristol-Myers Squibb Company (the “Company”) of her intention to retire from her position as Executive Vice President, General Counsel in 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sandra Leung retired as Executive Vice President, General Counsel at BRISTOL MYERS SQUIBB CO.

Action: retired
Role: Executive Vice President, General Counsel

Exact text from the filing

On February 14 , 2025, Sandra Leung notified Bristol-Myers Squibb Company (the “Company”) of her intention to retire from her position as Executive Vice President, General Counsel in 2025.

View on SEC.gov

BRISTOL MYERS SQUIBB CO filing history →

Source: SEC EDGAR

accession 0001140361-25-005012

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.